Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Virella

53 views

Published on

SHAPE Society

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Virella

  1. 1. Silvana Vielma,MD Gregor Krings,BS Maria Lopes-Virella, MD, PhD Medical University of South Carolina and Ralph Johnson VA Medical Center, Charleston, SC Chlamydophila pneumoniaeChlamydophila pneumoniae InducesInduces ICAM-1 Expression In Human AorticICAM-1 Expression In Human Aortic Endothelial CellsEndothelial Cells Via Protein Kinase C - DependentVia Protein Kinase C - Dependent Activation of Nuclear Factor-Activation of Nuclear Factor-κκBB
  2. 2. ENDOTHELIAL CELL DYSFUNCTIONENDOTHELIAL CELL DYSFUNCTION Cardiovascular Disease StartsStarts and EndsEnds with Endothelial Cell Dysfunction
  3. 3. Factors Leading to EndothelialFactors Leading to Endothelial DysfunctionDysfunction • ConventionalConventional: Dyslipidemia, Hyperglycemia, Smoking • Non-ConventionalNon-Conventional: – Increased Homocysteine, Angiotensin II, Pro- thrombotic Factors, Pro-Inflammatory Factors, Oxidative Stress – Infectious Processes: Cytomegalovirus and other viral infections , C. pneumoniae
  4. 4. C. pneumoniae and Arteriosclerosis • C. pneumoniae has an epidemiological link with arteriosclerosis and acute cardiovascular events • C. pneumoniae has been detected in carotid, abdominal aorta, coronary , femoral, pulmonary and popliteal arteries • C. pneumoniae is able to replicate in macrophages, endothelial and smooth muscle cells
  5. 5. C. pneumoniae Infects and Activates Endothelial Cells Monocyte V-CAM-1 E-Selectin ICAM-1 Adhesion molecules Induction of Chemokines IL-8, MCP-1 C. pneumoniae Elementary bodies Endothelial cells
  6. 6. ADHESION MOLECULESADHESION MOLECULES • Activation of Endothelial Cells by C. pneumoniae leads to increased expression of adhesion molecules and, as a consequence, increased adherence of monocytes to the endothelium, an early hallmark of atherogenesis • Adhesion molecules: – serve as mediators of cell-cell and cell-matrix interactions – participate in cell migration and signaling functions
  7. 7. Sequential steps of leukocyte adhesion Capture/Tethering Rolling Firm Adhesion Transmigration L-selectin P-selectin E-selectin Integrins, ICAM,VCAM ICAM PECAM Endothelial cells Price et. al. 1999
  8. 8. RATIONALE and GOALS It is known that C. pneumoniae activates p42/p44 (ERK1/2) and NF-κB in endothelial cells. Nothing is known, however, about regulation of ICAM-1 expression in chlamydia- infected HAEC. Thus the GOALGOAL of this study is: To determine which signaling transductionTo determine which signaling transduction pathways are involved in the regulation of ICAM-1pathways are involved in the regulation of ICAM-1 byby C. pneumoniaeC. pneumoniae in human aortic endothelial cellsin human aortic endothelial cells
  9. 9. Structure and regulation of ICAM-1 promoter ARE ICAM-1ICAM-1 TATAIRE TATA H2O2 IL-1β TNF AP-1 AP-1/ETS AP-1/ETS NF-kB C/EBP-AP-3 TFIID AP-1 C/EBP NF-kB Ets-1 STAT Sp1 AP-2 TFIID IFN-γ • Major intracellular signal transduction pathways – NF-κB pathway – Mitogen-Activated Protein (MAP) kinase (ERK, JNK, and p38) pathway – Protein kinase C (PKC) pathway
  10. 10. Protocol to infect HAEC with C. pneumoniae AR39 (ATCC) Cycloheximide Tx Hep-2 cells Chamber-slide system Mechanical dysruption and sonication IF staining Rocker platform x 2h at 37°C Incubation, 37°C, 1h MOI: 5-10 EB/cell HAEC Differential centrifugation
  11. 11. Time Course Expression of ICAM-1 in C. pneumoniae-Infected Human Aortic Endothelial Cells NI: Non-infected TNF: TNF-treated cells Cp: C.pneumoniae infected cells UV: Cells infected with UV-treated Cp H: Cells infected with Heat-inactivated Cp M: Mock cells
  12. 12. Time dependent activation of MAPK pathway in C. pneumoniae-infected HAEC
  13. 13. ICAM-1 expression by C.pneumoniae- infected HAEC is not mediated by MAPK Activation
  14. 14. NF-κB activation mediates C. pneumoniae- induced ICAM-1 expression NI: Non-infected cells TNF: TNF-treated cells CAPE: Caffeic acid phenethyl ester
  15. 15. ICAM-1 expression induced by C. pneumoniae is PKC-dependent Cy:Cytosol M: Membrane NI:Non-infected cells Cal C: Calphostin C Bis I: Bisindolyl- maleimide I
  16. 16. PKC isozymes depletion in C. pneumoniae-infected HAEC Cy: Cytosol M: Membrane NI: Non-infected cells PMA: PMA-treated cells
  17. 17. ICAM-1 up-regulation in C. pneumoniae- infected cells is PKC and NF-κB dependent NI:Non-infected cells TNF:TNF-treated cells Cal C: Calphostin C Bay: Bay 117085
  18. 18. Summary of ResultsSummary of Results • The up-regulation of ICAM-1 expression in C. pneumoniae- infected HAEC is time-dependent. Heat and UV inactivation of C. pneumoniae elementary bodies completely abolished the upregulation of ICAM-1 • Up-regulation of ICAM-1 expression in C. pneumoniae-infected HAEC is not mediated by MAPK activation • Inhibition of NF-κB activation completely abolishes C. pneumoniae-induced ICAM-1 expression by HAEC • ICAM-1 upregulation in C. pneumoniae-stimulated HAEC is PKC dependent • Activation of PKC leads to NF-κB activation and that, in turn, leads to increased transcription of the ICAM-1 gene
  19. 19. C. pneumoniae’s EB HAEC Toll-like receptors Leucine-like receptors? ICAM-1 NIK IKKγ IKKα IKKβ IkB- p and ubiquination NF-kB translocation P65(RelA) cSrc PKCCalphostinC CAPE BAY117085 U0126 PD98059 c-Fos, Ets-1, Sap1, STAT c-Raf-1 MEK1/2 ERK1/2 c-Jun JNK SAPK MEKK1 MKK4 IkB NF-kB Signal transduction pathways that mediate ICAM-1Signal transduction pathways that mediate ICAM-1 up-regulation inup-regulation in C. pneumoniae-C. pneumoniae-infected HAECinfected HAEC
  20. 20. CONCLUSIONSCONCLUSIONS 1. We have shown for the first time that PKC-mediated activation of NF-kB by C. pneumoniae leads to a specific up-regulation of ICAM-1 in human aortic endothelial cells 2. Up-regulation of ICAM-1 by C. pneumoniae contributes to the chronic inflammatory events associated with atherosclerosis
  21. 21. Questions?Questions? Vielma SA, Kreggs G, Lopes-Virella MF:Vielma SA, Kreggs G, Lopes-Virella MF: Circulation ResearchCirculation Research 92: 1130-7, 200392: 1130-7, 2003

×